biotech deals

Eli Lilly puts up $100M for 5-target deal with China's InnoCare

Lilly has committed $100 million in upfront and near-term payments, plus up to $3.25 billion in milestones, to form a five-target drug discovery pact.

Nick Paul Taylor Sep 24, 2026 2:39am

Novo corrals 3 new early-stage obesity drugs from Kallyope

Sep 18, 2026 11:23am

GSK pens $1.3B Hutchmed deal for KRAS-EGFR cancer asset

Sep 3, 2026 7:45am

graphic image of China flags overlapping with US flags

Eli Lilly reunites with Abbisko in $1.9B, multitarget R&D pact

Jun 24, 2026 7:47am

Takeda ends mRNA research pact with Japanese drug discoverer

Apr 14, 2026 9:57am

Merck hands over $20M in IBD target deal with Quotient

Mar 24, 2026 6:00am